CAD 0.17
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 4.85 Million CAD | -32.28% |
2022 | 7.17 Million CAD | -12.64% |
2021 | 8.21 Million CAD | -9.62% |
2020 | 9.08 Million CAD | -57.29% |
2019 | 21.27 Million CAD | 4.53% |
2018 | 20.35 Million CAD | 395.26% |
2017 | 4.1 Million CAD | 310.39% |
2016 | 1 Million CAD | 3650.05% |
2015 | 26.7 Thousand CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q4 | 4.85 Million CAD | -15.59% |
2023 Q3 | 5.75 Million CAD | -1.08% |
2023 Q2 | 5.81 Million CAD | -18.63% |
2023 Q1 | 7.15 Million CAD | -0.33% |
2022 Q1 | 8.12 Million CAD | -1.1% |
2022 Q4 | 7.17 Million CAD | 3.22% |
2022 Q3 | 6.95 Million CAD | -13.33% |
2022 Q2 | 8.01 Million CAD | -1.27% |
2021 Q1 | 8.6 Million CAD | 0.0% |
2021 Q4 | 8.21 Million CAD | 6.32% |
2021 Q3 | 7.72 Million CAD | -2.82% |
2021 Q2 | 7.94 Million CAD | -7.64% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 5.38 Million CAD | 9.704% |
CanadaBis Capital Inc. | 15.61 Million CAD | 68.897% |
Decibel Cannabis Company Inc. | 96.79 Million CAD | 94.981% |
Entourage Health Corp. | 178.68 Million CAD | 97.281% |
Lifeist Wellness Inc. | 9.94 Million CAD | 51.13% |
Cannara Biotech Inc. | 61.77 Million CAD | 92.136% |
Medicure Inc. | 8.16 Million CAD | 40.488% |
PharmaCielo Ltd. | 23.96 Million CAD | 79.732% |
Rubicon Organics Inc. | 16.99 Million CAD | 71.418% |
BioSyent Inc. | 6.76 Million CAD | 28.234% |
Voyageur Pharmaceuticals Ltd. | 727.87 Thousand CAD | -567.42% |